The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells
Abstract YAP and TAZ, the Hippo pathway terminal transcriptional activators, are frequently upregulated in cancers.In tumor cells, they have been mainly associated with increased tumorigenesis controlling different aspects from cell cycle regulation, stemness, or resistance to chemotherapies.In fewer cases, they have also been Fusible Non-Woven sho